Dynamic Model for Predicting Death Within 12 Months in Patients With Primary or Post–Polycythemia Vera/Essential Thrombocythemia Myelofibrosis

PURPOSE: Current prognostic tools in myelofibrosis (MF) fail to identify patients at the highest risk of death and are limited by their applicability only to the time of diagnosis. We aimed to define an accelerated phase (AP) in MF by characterizing disease features that can identify patients with m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Tam, Constantine S., Kantarjian, Hagop, Cortes, Jorge, Lynn, Alice, Pierce, Sherry, Zhou, Lingsha, Keating, Michael J., Thomas, Deborah A., Verstovsek, Srdan
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2009
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4979081/
https://ncbi.nlm.nih.gov/pubmed/19786661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.22.8833
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados